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Summary
Background: Bronchoscopic lung biopsy using ﬂuoroscopic guidance is the standard
procedure for the diagnosis of peripheral pulmonary lesions. Peripheral lesions can also be
biopsied using endobronchial ultrasound (EBUS) guidance, which is equally effective and
does not expose the patient or staff to radiation.
Objectives: We determined the diagnostic yield of EBUS- and ﬂuoroscopic-guided
bronchoscopic lung biopsy (BLB) under everyday, clinical conditions, and compared our
results to published data.
Patients and Methods: A total of 304 consecutive patients with peripheral pulmonary
lesions who underwent EBUS- or ﬂuoroscopy-guided BLB were included in this study.
We compared the diagnostic yield of EBUS- and ﬂuoroscopy-guided bronchoscopic lung
biopsy (BLB) to determine which method is more sensitive for the diagnosis of peripheral
pulmonary lesions.
Results: EBUS-guided BLB was performed in 116 patients, and ﬂuoroscopy-guided BLB was
used in 188. The median diameter of the peripheral pulmonary lesions in the EBUS group
was 31.5mm (9–125) compared with 34.5mm (6–100) in the ﬂuoroscopy group. Diagnostic
biopsy samples were obtained from 89 (77%) patients using EBUS and from 139 (74%)
patients using ﬂuoroscopy-guided BLB. The difference in the diagnostic outcome between
these methods was not statistically signiﬁcant.
Conclusion: The results of our study showed that the diagnostic yield was similar between
EBUS- and ﬂuoroscopy-guided BLB, although our ﬁndings suggest that more positive
outcomes are expected with EBUS. The EBUS procedure is safer because it does not involve
exposure of the patient or medical staff to radiation.
© 2011 Elsevier Ltd. All rights reserved.
Introduction
Bronchoscopic lung biopsy (BLB) of peripheral pulmonary
lesions using ﬂuoroscopic guidance is a standard diagnostic
procedure that has been used for more than thirty years;
however, the diagnostic yield of this method varies widely
from 18% to 75%.1–5 Endobronchial ultrasound (EBUS) BLB
has been shown to be as accurate as ﬂuoroscopy-guided BLB,
* Corresponding author. Nadja Triller MD. University Clinic
of Respiratory and Allergic Diseases Golnik, Golnik 36, 4204
Golnik, Slovenia. Tel.: +386 4 2569 100; fax: +386 4 2569 17.
E-mail: nadja.triller@klinika-golnik.si (N. Triller).
and it is a minimally invasive procedure with high sensitivity
that eliminates the risk of radiation exposure for patients
and staff. An additional advantage of EBUS-guided BLB is
the ability to obtain samples from ﬂuoroscopically invisible
lesions,6 such as cases with massive pleural effusion or
calciﬁed pleural plaques. Pulmonary lesions can be precisely
located using EBUS because the air content of the lung
parenchyma completely reﬂects the ultrasound signal. Many
prospective randomised studies have demonstrated that
peripheral pulmonary lesions can be diagnosed using EBUS-
guided BLB.6–8 Visualisation of the inner structures of lesions
may indicate their histology,6,8 although ultrasound images
0954-6111$ – see front matter © 2011 Elsevier Ltd. All rights reserved.
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Table 1
Patient and lesion characteristics
EBUS guided BLB Fluoroscopic guided BLB
Patients, n (F/M) 116 (37/79) 188 (58/130)
Age, yrs, median (range) 66.5 (34–88) 66 (30–87)
Size of the lesion (mm), median (range) 31.5 (9–125) 34.5 (6–100)
Right upper lobe, n (%) 40 (34) 57 (30)
Middle lobe, n (%) 1 (1) 16 (8.5)
Right lower lobe, n (%) 24 (21) 27 (14)
Left upper lobe, n (%) 36 (31) 48 (26)
Left lower lobe, n (%) 15 (13) 40 (21)
Total 116 188
are not sufﬁcient to establish a diagnosis of the underlying
pathology.
In this study, we compared the diagnostic yields of
EBUS- and ﬂuoroscopy-guided BLB of peripheral pulmonary
lesions in a typical clinical environment.
Patients and Methods
This study was designed to compare the diagnostic
yield of EBUS- and ﬂuoroscopy-guided BLB of peripheral
pulmonary lesions detected on computer tomography (CT)
images. We included all consecutive patients over a one-
year period who presented with measurable peripheral
pulmonary lesions and no evidence of endobronchial
pathology. All chest CTs were reviewed, and the size of
each lesion was recorded. Patients underwent bronchoscopy
after providing written informed consent. Bronchoscopic
procedures were performed under topical anaesthesia in a
standard fashion by ﬁve experienced bronchoscopists. After
accurate inspection of the endobronchial tree, BLB was
performed either with EBUS or ﬂuoroscopic guidance based
on the choice of the bronchoscopist.
A miniature ultrasound probe (20MHz, mechanical radial-
type UM-S20–20R; Olympus Optical, Tokyo, Japan) with
an outer diameter of 1.7mm was used. The probe was
connected to an endoscopic ultrasound system (EU-M30,
Olympus Optical). Fluoroscopy was performed using a
C-arm. After ﬂuoroscopic localisation of the lesion and
introduction of the forceps, ﬁve biopsies were obtained for
each lesion.
For EBUS-guided BLB, the EBUS probe was inserted into
several bronchi in the suspected area. After detection of the
(a) (b)
Fig. 1. Peripheral pulmonary lesion in the right upper lobe
(a) on CT (arrow) and (b) in endobronchial ultrasound (EBUS)
image.
lesion, the ultrasound probe was removed, and the forceps
was introduced into the same bronchus (Fig. 1). Five samples
of tissue from the target area were collected.
Statistical analysis
For the evaluation of the results, we used Chi-squared tests
and the Likelihood Ratio (LR) to generate contingency tables
with the data. T-tests and analysis of variance were applied
to compare the distributions of continuous data among
subgroups of patients.
Data were processed and analysed with SPSS v.16.0 for
Windows.
Results
We examined 304 patients with peripheral pulmonary lesions
who underwent bronchoscopy between January and Decem-
ber 2006. EBUS-guided BLB was performed in 116 patients,
and ﬂuoroscopy-guided BLB was performed in 188 patients.
The groups were equally distributed with respect to age,
gender, size and location of the lesion (Table 1). Although the
mean diameter of the lesions was 3mm smaller in the EBUS
patients (31.5mm) than it was in the ﬂuoroscopy patients
(34.5mm), the difference was not found to be statistically
signiﬁcant. Bronchoscopic procedures were performed under
topical anaesthesia using a standard procedure by ﬁve
experienced bronchoscopists. Both methods were used at
a similar ratio, that was not statistically different (chi-
squared = 1.069, df = 4, p > 0.05) (Table 2).
Biopsy specimens were sufﬁcient for establishing diag-
noses of malignant or benign disease in 89 (77%) patients
who underwent EBUS-guided bronchoscopy and 139 (74%)
patients who underwent ﬂuoroscopy-guided bronchoscopy,
and there was a high prevalence of malignant disease in
both groups (82% in the EBUS group and 72% in ﬂuoroscopy
group). Cases for which a diagnosis could not be determined
using either technique were diagnosed using other methods:
65 patients were diagnosed using CT-guided percutaneous
needle aspiration cytology, 6 patients were diagnosed using
ultrasound-guided percutaneous needle aspiration cytology,
5 were diagnosed using a surgical procedure, and 4 were
diagnosed using radiological methods and clinical follow-up.
Final diagnoses obtained using BLB are listed in Table 3, and
the diagnostic yield of EBUS-guided BLB according to lesion
location is provided in Table 4. We found that the ratios of
positive and negative diagnostic outcomes in various lobar
locations, including upper, middle and lower, did not differ
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Table 2
Number of procedures per bronchoscopists
Bronchoscopist EBUS guided BLB n (%) Fluoroscopic guided BLB, n (%) Total
1 31 (41) 45 (59) 76
2 37 (40) 56 (60) 93
3 16 (36) 28 (64) 44
4 11 (31) 24 (69) 35
5 21 (37) 35 (63) 56
Total 116 (38) 188 (62) 304
Table 3
Established diagnosis obtained by BLB
Diagnosis EBUS guided BLB Fluoroscopic guided BLB
Adenocarcinoma 34 48
Squamous cell cancer 15 27
Large cell cancer 5 6
Small cell cancer 5 9
Non small cell cancer 1 5
Lymphoma 3 1
Carcinoid 0 1
Metastatic tumour 9 5
Pneumonia 7 12
Tuberculosis 1 3
Nonspeciﬁc inﬂammation 6 18
Absces 1 2
Sarcoidosis 1 4
Total 89/116 (77%) 139/188 (74%)
Table 4
Diagnostic yield of EBUS guided BLB by location of the lesion
EBUS RTG Chi-square test statistics (df = 1) p
Right upper lobe, n (%) 28/40 (70) 43/57 (77) 0.552
Middle lobe, n (%) 1/1 (100) 12/16 (75) 0.423
Right lower lobe, n (%) 21/24 (88) 19/27 (70) 0.138
Left upper lobe, n (%) 26/36 (72) 36/48 (75) 0.774
Left lower lobe, n (%) 13/15 (87) 29/40 (72) 0.320
Fig. 2. The comparison of diagnostic yields between EBUS and
ﬂuoroscopic procedure in three different lobes.
between EBUS- and ﬂuoroscopy-guided bronchoscopy. The
lobar location had much more of an inﬂuence on diagnostic
yield for the EBUS-guided biopsies (Fig. 2), and we found
that this method performed better than the ﬂuoroscopic
method in the lower lobes (LR = 3.387, df = 1, p = 0.066).
The difference between the diagnostic outcomes of both
methods was not statistically signiﬁcant (LR = 0.299, df = 1,
p = 0.584).
We did not observe any serious complications during the
procedure; patients tolerated both methods under topical
anaesthesia equally well.
Representative case
A patient who underwent EBUS-guided BLB had a 20×18mm
solitary peripheral lesion that was suggestive of lung cancer
in the right upper lobe. A miniature probe was introduced
into the area. Normal tissue typically appears similar to a
“snowstorm” (Fig. 3a). In the case presented here, the EBUS
image conﬁrmed the presence of a hypoechoic lesion in the
suspected area at the margins of the normal tissue (Fig. 3b),
indicating the presence of a solid tumour.
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Fig. 3. Endobronchial ultrasound (EBUS) image: (a) normal lung
tissue like a snowstorm, and (b) marginated hyperechoic signal –
tumor.
Discussion
Peripheral pulmonary lesions can be successfully diagnosed
either with EBUS- or ﬂuoroscopy-guided BLB. Although
multiple studies have investigated diagnostic yield of EBUS
guided BLB only few English-language studies have compared
diagnostic yield of EBUS- and ﬂuoroscopy-guided TBB.7 To
our knowledge, our study represents one of the largest
of its kind.9 The primary limitation of this study is that
the sampling method was not randomised according to the
variability of the lesion location, which seems to be an
important factor in the decision of which method should
be used for the examination in each case. We found that
our results were not biased because all ﬁve bronchoscopists
used both methods at a similar ratio (Table 3).
The diagnostic yield was 77% for EBUS-guided BLB and 74%
for ﬂuoroscopy-guided BLB. Similar studies in the ﬁeld have
noticed that the sensitivity of EBUS-guided BLB for diagnosis
of peripheral pulmonary lesions varies from 44% to 92%.
Sensitivity depends on the size and location of the lesion.6–13
Many studies have reported that better results could be
achieved by using a guiding sheath,6,8,13,14 especially for
lesions <3 cm.14 We did not use guiding sheath and even
though statistically not signiﬁcant, the yield for lesions
<3 cm in size tended to be better than with ﬂuoroscopy.
However, some studies determined that the position of the
probe (within or adjacent to the lesion), and not size of
the lesion, was the only signiﬁcant factor that predicted
diagnostic yield. We agree that the position of the lesion
is very important, and we obtained biopsies only when the
probe was clearly positioned within the lesion.
Checani15 reported that the most difﬁcult lesions to
diagnose using ﬂuoroscopic biopsy were located in the upper
lobes, apical segments and lower lobe basal segments.
Kurimoto demonstrated6 that the worst yield for EBUS-
guided BLB was achieved in the left upper apical-posterior
segment (40%) because of difﬁculties during the insertion of
the probe, whereas the lower lobes are easier to access,
suggesting that EBUS-guided BLB is superior to ﬂuoroscopy
in the lower lobes. These ﬁndings are consistent with the
results of our study.
Conclusion
The EBUS procedure is safer because it does not involve
exposure of the patient or medical staff to radiation. This
method performed better for the diagnosis of lesions located
in the lower lobes and had the lowest sensitivity in the upper
lobes.
We conclude that EBUS is superior compared to
ﬂuoroscopy for the diagnosis of lesions in the lower lobes.
However, it would not be appropriate to simply replace
EBUS with ﬂuoroscopy-guided BLB. Bronchoscopists should
become experienced with both methods to achieve the
best diagnostic results. Further studies are required to
clearly outline the selection process and to help clinicians
determine the optimal approach for individual patients.
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